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A common assumption in genomics research is that the use of ethnic categories has the potential to lead to
ethnic stigmatisation e particularly when the research is done on minority populations. Yet few empirical
studies have sought to investigate the relation between genomics and stigma, and fewer still with a focus on
Africa. In this paper, we investigate the potential for genomics research to lead to harms to ethnic groups.We
carried out 49 semi-structured, open-ended interviews with stakeholders in a current medical genomics
research project in Africa, MalariaGEN. Interviews were conducted with MalariaGEN researchers, ﬁeld-
workers, members of three ethics committees who reviewed MalariaGEN project proposals, and with
membersof the two fundingbodiesproviding support to theMalariaGENproject. Interviewswere conducted
in Kenya, The Gambia and the UK between June 2008 and October 2009. They covered a range of aspects
relating to the use of ethnicity in the genomics project, including views on adverse effects of the inclusion of
ethnicity in such research. Drawing on the empirical data, we argue that the risk of harm to ethnic groups is
likely to be more acute in speciﬁc types of genomics research. We develop a typology of research questions
and projects that carry a greater risk of harm to the populations included in genomics research.We conclude
that the potential of generating harm to ethnic groups in genomics research is present if research includes
populations that are already stigmatised or discriminated against, or where the research investigates
questions with particular normative implications. We identify a clear need for genomics researchers to take
account of the social context of thework they are proposing to do, including understanding the local realities
and relations between ethnic groups, and whether diseases are already stigmatised.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license. Introduction
With the rise of genomic studies, literature on the ethical
implications of such work has proliferated (Caulﬁeld et al., 2008;
Kaye, Boddington, de Vries, Hawkins, & Melham, 2010). Few of
these publications are, however, directly relevant to the African
context (De Vries et al., 2011). Major concerns have been raisedpartment of Public Health,
. de Vries), muminatou@
llcome.org (T.N. Williams),
ichael.parker@ethox.ox.ac.uk
Fitzpatrick).
-NC-ND license. about the possible effects of genomics research in causing harm to
the population groups included in the study, with the most speciﬁc
form of harm being stigmatisation of ethnic groups (Foster & Sharp,
2006; Goodman, 1996; WHO, 2002). But although stigmatisation is
frequently said to be a potential harmful consequence of genomics
research, hardly any scholarly work has investigated the nature of
this challenge. As a result, little is known about the processes of
stigmatisationwhichmay result from genomic research, about how
researchers and other stakeholders in research conceive them, and
about what may be done to ameliorate or avoid such consequences.
This paper aims to explore the nature of potential harm for pop-
ulation groups included in a genome-wide association (GWA) study
in Africa, when such harm might occur, and which measures could
reduce the risk.
1 The research team for this study consisted of JdV, MP and RF. JdV and MP had
previously been working with MalariaGEN as bioethicists. RF was not involved in
the MalariaGEN project. The study received separate funding and was ﬁnancially
and academically independent of the MalariaGEN project.
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compare genetic data derived from individuals with and without
a particular disease, in order to identify genetic variants that are
associated with the disease under study (for a good description see
Fujimura & Rajagopalan, 2011). In this paper, we describe the
results of a qualitative research study that was conducted within
a GWA study on malaria, MalariaGEN (Jallow et al., 2009).
Themajority of genomic studies conducted to date have been on
populations of European descent (Need & Goldstein, 2009). Only
a fraction has included populations from Africa (Rosenberg et al.,
2010). The exclusion of African populations from genomic studies
may promote or prolong existing global health inequalities, in
particular if such research leads to knowledge that is of clinical
relevance (Coloma & Harris, 2009; Newport & Rotimi, 2009). It is
therefore very important that genomics research methods are also
used for the investigation of diseases primarily affecting patients on
the African continent.
Such studies are not without methodological difﬁculties
however. African people are genetically very diverse (Rosenberg
et al., 2010), and this diversity causes considerable methodolog-
ical challenges in expanding GWA studies to the African continent
(Teo, Small, & Kwiatkowski, 2010). Population substructure e i.e.
when members of a population have a shared genetic background
e has the potential to confound GWA analyses and lead to false
positive associations between disease and clinical outcome. One
approach has been to match samples according to population
groups. In African settings, this generally means matching samples
by ethnic group.
The effect of including ethnicity in the GWA studies, however, is
that two of the main outcomes of such research e research results
and genomic datasets e are thereby correlated with ethnicity. For
instance, although the MalariaGEN project did not set out to study
ethnic groups, researchers considered the collection of information
on participants’ ethnicity to be essential for analysis. As a result,
however, the genomic datasets produced were speciﬁc for ethnic
groups. A rich literature exists around social and ethical issues
raised by the use of racial and ethnic categories in genomics
research. Important concerns relate to the measurement of these
categories (Hunt & Megyesi, 2008; Lee, 2009), appropriate ways of
reporting on group speciﬁc research ﬁndings (Martin, Ashcroft,
Ellison, Smart, & Tutton, 2007; Wensley & King, 2008), and
a possible revival of eugenic ideologies (Aultman, 2006). Scholars
have also criticised genomic and genetic models of disease that
overlook the ways in which diseases, as well as their perceived
severity and social impact, are culturally and institutionally
embedded within countries and population groups (Fullwiley,
2010). A detailed overview of these issues is not the purpose of
this paper. Excellent reviews of this literature can be found in
Reardon (2005), Frank (2007) and Koenig et al. (2008).
This literature, however, tends to be silent about the potential
for GWA studies to cause stigmatisation for ethnic groups included
in studies. When considering the relation between genomics and
stigma, authors seem to locate the potential for stigma in the
possibility to attribute genetic risk factors for particular diseases to
identiﬁable population groups (Foster & Sharp, 2006; Goodman,
1996; WHO, 2002). Such an understanding seems to be concor-
dant with views of stigma as a ‘mark’ e an understanding of stigma
that has been amply criticised as being overly simplistic (Greely,
2010; Parker & Aggleton, 2003; Phelan, 2005). Moreover, genomic
studies tend to focus on complex diseases, for which it is unlikely
that any one genetic variant will be identiﬁed that could explain
disease causation.
A small number of studies have investigated the relation
between stigma and research on single gene conditions such as
some forms of deafness. The majority of such studies have beenconducted in the US (Phelan, 2005; Sankar, Cho, Root Wolpe, &
Schairer, 2006), although some studies have been conducted
outside of the US (Meiser, Mitchell, McGirr, Van Herten, & Schoﬁeld,
2005). With the exception of one study on consent for a genomic
study on podoconiosis (Tekola et al., 2009), no such studies have
been conducted on the African continent. But with the expansion of
genomics methodology to Africa, it is increasingly pertinent to
understand the potential of genomics research in Africa to impact
on stigma.
Methods
MalariaGEN
To investigate the nature of potential harm for ethnic groups
arising out of GWA research in Africa, we conducted qualitative
interviews with 49 stakeholders involved with a current GWA
study in Africa. MalariaGEN was a partnership between malaria
researchers in over 20 countries across the globe (The MalariaGEN
Consortium, 2008). The network was composed of research groups
that each conduct their own research on topics relating to malaria,
and all participated in some component of the GWA study. For the
purposes of this study, we were interested in each group’s role in
and perspectives on the use of ethnicity in the GWA study.
On the African continent, samples were collected by 13 research
groups from 11 countries. With the exception of only a small subset
of samples, all samples were collected with ethnic identiﬁers,
which were used to account for population stratiﬁcation. Data on
the ethnicity of MalariaGEN research participants was mostly self-
deﬁned, and sometimes triangulated with information about
language and the ethnicity of parents or grandparents. Samples
were donated by participants from at least 30 different ethnic
groups from across Africa. MalariaGEN participant recruitment did
not initially target members of particular groups but included all
malaria patients presenting at selected healthcare facilities.
However, the research design did subsequently require that
samples from healthy volunteers e the controls in the experiment
e were matched in terms of age, gender and ethnicity. The
recruitment of samples from healthy volunteers was therefore
ethnic-group speciﬁc. Although samples were collected from only
a small number of research participants per group, in presentations
and publications the results were treated as if they were relevant
for the entire ethnic group e an interesting and important issue
that we intend to discuss in a future paper. TheMalariaGEN consent
process did not generally include a description of the need to collect
information about participants’ ethnicity, or any possible harm
arising out of the use of ethnicity in the research project. In some
cases, however, this was discussed during the community consul-
tation process. For an example of a community consultation process
around a MalariaGEN project at one particular research site, see
Tindana et al. (2007).1
Selection of interview participants
Interviews were conducted at two MalariaGEN project sites in
Africa and in the UK, between June 2008 and October 2009. The two
sites in Africae the KEMRI-Wellcome Overseas Programme in Kiliﬁ,
Kenya and the MRC Labs in Fajara, The Gambia e had experience
with genomics research prior to MalariaGEN, and had also hosted
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Small, 2006; Marsh, Kamuya, Rowa, Gikonyo, & Molyneux, 2008).
Both these research programmes receive primary funding from
institutions in the UK. These two sites were chosen because they
were amongst the few in the MalariaGEN study that had prior
experience with genomics research, and because they were
expected to contribute the largest number of samples to the
MalariaGEN study. The two MalariaGEN research groups in Kenya
and in The Gambia both conduct a broad range of malaria research
but neither of these groups is primarily composed of genomic
researchers.
The main objective of the interviews was to identify ethical
issues in the use of ethnic data in genomics research in Africa. Four
categories of stakeholders were identiﬁed that were considered
important for this project. These were: MalariaGEN researchers (20
interviews); MalariaGEN ﬁeldworkers (15 interviews); members of
3 research ethics committees that reviewed MalariaGEN project
proposals (12 interviews); and members of the funding bodies that
supported the MalariaGEN project (2 interviews). Fieldworkers
were included as a semi-lay group of interviewees. They are the
members of the research team that are normally tasked with study
participant recruitment. All ﬁeldworkers were originally from the
communities and populations from which MalariaGEN research
participants were recruited. In Kenya, most ﬁeldworkers were
trained up to and including secondary school level. In Gambia, the
ﬁeldworkers were trained nurses.
People donating samples to the MalariaGEN project e the
original research participants e were not included in this study for
a number of reasons (see Limitations below). Limited guidance in
literature about what the issues might be complicated the devel-
opment of research tools appropriate for conducting research with
the original MalariaGEN participants. In addition, we considered it
necessary that interviewees had some prior knowledge of
concepts like ‘genomics’, ‘ethics’ and the reasons for collecting
ethnic data.
All but one of the interviews were conducted in person by the
same interviewer. One interview was conducted over the phone.
Detailed ﬁeldnotes were recorded throughout the project.
In the discussion of our results, interview quotes are identiﬁed
by the following acronyms: R indicates MalariaGEN researchers,
FW indicates MalariaGEN Fieldworkers and REC indicates
a member of an ethics committee that reviewed the original
MalariaGEN proposal.
Interview guides
The interview guides were developed in consultation with
colleagues and with two informants at the research sites in Kenya
and The Gambia. Although the themes covered in the interviews
were similar across all stakeholder categories, the interview guides
were adapted to suit the experience of the participants in the four
categories. For instance, questions about the actual measurement of
ethnicity were suitable for researchers and ﬁeldworkers, but were
not appropriate for ethics committee members. The interviews
covered issues in the current practice of using, deﬁning and
measuring ethnicity; awareness of particular ethical issues in using
ethnicity for genomics research; issues in identifying ethnic groups
and genomic data in research and publications; implications of
labelling ethnic groups; issues in the sharing and re-use of ethnic
data in genomics; and possible solutions to the challenges identi-
ﬁed. Although interviews gave extensive opportunity for adverse
effects of genomics to be raised or discussed, the terms ‘stigma’ or
‘stigmatisation’ were not introduced by the interviewer. Where the
interviewee used the term, interviews explored the meaning of the
term and its relation to genomics research.Data analysis
The processes of data collection and analysis were conducted
iteratively during this study; transcripts of interviews were ana-
lysed throughout the project in tandem with data collection and
new insights were integrated into subsequent interviews. This
process continued until no new issues, themes or insights were
generated during the interviews or coding. At this point, the study
reached so-called ‘saturation’ (Mason, 2010), and interviewing was
stopped subsequently.
Interviews were recorded and transcribed verbatim. Data was
analysed inductively using specialized software (QSR, 2009). The
ﬁrst stage of open coding was followed by hierarchical coding
where emerging patterns and themes in the data were estab-
lished (Quinn-Patton, 2002). Interpretations of the data were
discussed amongst the research team. Early insights were
explored critically in subsequent rounds of coding and analysis to
explore their authenticity and appropriateness. The use of
detailed ﬁeldnotes was essential in this process, to trace the
development of insights and understandings, and to offer
a means for critical reﬂection.Limitations of the study
The aim of this project was to develop a better understanding
of the ethical issues raised by the use of ethnic data in a partic-
ular genomic project in Africa, and not to investigate these issues
in the speciﬁc research contexts of two research centres in
Africa. For this reason, results are not reported for the two
research sites speciﬁcally. No major systematic differences were
found between the views of the various stakeholders. Where we
found some divergence of opinion, we have indicated this in the
text.
A second important limitation of this study is that MalariaGEN
research participants were not included in this study. Our work
therefore does not elucidate the relation between genomics
research and stigma as a lived experience for research partici-
pants and their communities (Yang et al., 2007). It will be
essential to draw on the ﬁndings reported in this paper in the
design of a research project aimed at examining research
participants’ views on and experiences of stigma in genomics
research in Africa.
Lastly, our study examined the perspectives of a variety of
stakeholders in genomics research in Africa on the potential for
genomics research to contribute to ethnic stigmatisation. Although
we have generated a better understanding of whether, when and
how ethnic group stigma could arise in relation to genomics
research in Africa, this relation remains largely hypothetical. What
will be required next is to monitor in practice whether stigma or
harm actually emerge in relation to genomics research on the
African continent, now and in the future, and how it affects the lives
of those participating in research, or affected with particular
conditions.Ethics approval and consent
This study was reviewed and approved by the Oxford Tropical
Research Ethics Committee in the UK (OX 22-08), the KEMRI/
National Ethical Review Committee (SCC4547) and The Gambia
Government/MRC Laboratories Joint Ethics Committee
(SCC1137v2). All interviewees gave informed consent prior to the
interview. Consent was given for participation in the study, for
recording of the interview, and for use of anonymised quotes in
research materials.
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Beneﬁts of using ethnicity in genomics research in Africa
Interviewees described a number of advantages of using
ethnicity in genomics research. Although most interviewees (34
out of 48) identiﬁed beneﬁts to the use of ethnic categories in the
MalariaGEN project, a small number of interviewees (9 total; 1
ﬁeldworker, 4 each of ethics committee members and researchers)
considered the focus on genetic diversity between ethnic groups in
genomics studies as particularly positive. One reason is that the
inclusion of ethnicity in genomics research enables the use of this
methodology for resource-restrained sites and projects. Namely,
although alternatives exist for the use of population categories
(described for instance by Fujimura & Rajagopalan, 2011), such
alternatives are more costly as they involve the screening of larger
numbers of genetic variants.
“we are only genotyping the top 200 SNPs in new samples and of
course in those new samples we don’t have principal components
[.] I mean these big studies are really expensive and [.] even
though from my point of view since most of the analysis I do is on
the big datasets I don’t technically need [ethnicity], all [smaller
MalariaGEN] sites to do just the analysis on candidate genes and
things like that of they will.”(R).
When hundreds of thousands of genetic variants e also called
single nucleotide polymorphisms or SNPs e are typed per indi-
vidual, then one can use a statistical tool called ‘principal compo-
nent analysis’ to stratify project data into genetic ancestry clusters.
This obviates the need for using ethnic groups. But when the
resources only allow for the typing of a far smaller number of
variants in different populations then the use of population cate-
gories is considered essential to account for population stratiﬁca-
tion. In a severely resource-restrained setting, which is the case for
many research centres in Africa, interviewees considered this to be
an important beneﬁt to using ethnic categories.
Interviewees also described an additional motivation for using
ethnic categories in genomics research in Africa. Namely, they
considered that neglecting population differences in research is
a harmful response to historical abuses in the use of population
categories in research.
“Because of fascism and the Nazis, the experiments that were done
on certain ethnic groups, people were very reluctant to talk about
human difference you know. I think that we have enjoyed a good 50
years of pretending that human differences do not exist. So this is
an exaggerated political correctness that can backﬁre”(R).
Some interviewees also expressed the hope that genomics
would offer amore value-neutral catalogue of human history that is
based on genetic evidence. For these interviewees, such a catalogue
may be less biased than other ‘catalogues of variation’, such as ones
based on skin colour.
“So rather than having something relatively unimportant like skin
colour [.], you could actually have something that gives you a bit
more of a catalogue of variation across the genome to show you
relationships between groups. [.It’s] rather, having a less biased
catalogue of variation for ethnic groups”(R).
The hope that genomics research would offer a relatively value-
neutral catalogue of variation was shared not only by some
researchers, but also by one member of an ethics committee based
in an African country. This perspective seems to rest on the belief
that little social or normative value can and will be attributed to
genomic differences between populations or individuals. Processes
of stigmatisation normally rely on the identiﬁcation of differencethat can be relatively easily perceived (Link & Phelan, 2001), and
where value is attached to the difference. The hope that genomics
research could offer a catalogue of apparently insigniﬁcant differ-
ences that have not historically been stigmatised or considered of
normative value, was for some interviewees a reason to expand
these methods to all diseases and populations.
Potential for group harm in genomics research
At the same time, all research participants identiﬁed some form of
potential group harm relating to the use of ethnic categories in
genomics research. The most frequently deﬁned challenge was the
possibility that genomics research could lead to the clear linking of
(susceptibility to) diseases to particular ethnic groups. The fear is that
such information could be used as evidence of difference that is
rumoured to exist, to fuel animosity, or to afﬁrmthe social andcultural
superiority of one ethnic group over another, for instance when one
group is found to have some genetic resistance against diseases.
One important concern that the interviewees identiﬁedwas that
the genomic focus on ethnic difference could be seen to afﬁrm the
social and biological importance of these categories.
“one of the things I can see as potentially a problem is that saying
that groups are different genetically or saying that this group is
more similar to this group than this group perhaps legitimises
antagonism that already exists. Even if we try to stress that by far
and away most variation is shared by everyone, if we put out our
plots and say something like ‘this group is more related to this
group or this group is distinct from these other groups’ that
somewhat legitimises the fact that one group thinks of themselves
as different”(R).
For ﬁeldworkers, the potential harm is in ‘shaming people’,
which is a risk especially where genomics research describes
differences between ethnic groups and those differences have
normative implications. One possible harmful implication of using
ethnic groups in genomics research is that it could inﬂuence
opportunities for marriage for affected individuals or their family
members.
“I don’t think it would be [good] if we bring in the aspect of the tribe
[.] when people know that a particular tribe they have this
disease, [.] if it comes to marriage people will be shying away
from that particular [tribe] saying that okay they have this disease
and we know very well it’s not curable so it will be like
a disadvantage”(FW).
Overall, the nature of the harm that is described by interviewees
seems to relate to damage to the reputation, integrity or social
status of the population groups involved in the studies. Such
damage can be harmful in itself, but can also subsequently give rise
to discriminatory practices.
Many interviewees introduced the term ‘stigma’ to describe
such harm. Nearly all researchers (15 out of 19), ethics committee
members (10 out of 12) and funding body representatives (2 out of
2) used this term. Only a small number of ﬁeldworkers (5 out of 14)
also used this term to describe possible harm of using ethnicity in
genomics research. Ethics committee members for instance,
described that concerns over stigmawere discussed in their review
of genomics research proposals.
“Our concern has always been relating ﬁndings to tribes or to
ethnic groups because we felt that that could lead to people being
stigmatised or at the risk of being stigmatized”(REC).
When prompted to describe what they meant by the term,
interviewees deﬁned stigma mostly in terms of its consequences,
and then predominantly in terms of shame and social isolation.
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ridicule and solitude.
Interviewees tended to describe stigma as a trait that can be
mapped onto people.
“I can imagine that if there was a genetic trait that would be
understood by the people as being detrimental [.] I could
understand that people could be stigmatised if that population was
associated with that particular trait”(R).
The fear is that genomics research could come up with results
that “label” (REC) a particular group, that give “certain attributes”
(REC) to groups, and that allow others to “say evil things” (FW)
about members of the ethnic group. These ideas about how geno-
mics research could lead to stigma seem to be quite different from
the notion that genomics research could offer a value-neutral
‘catalogue of variation’ that we described before. For these inter-
viewees, the risk of harm arises in the translation of these ﬁndings
into socially meaningful terms and concepts. Whereas on the one
hand, these interviewees consider genomic information to be
innocuous e for instance, when it concerns statistical information
about group prevalence of a particular genetic variant that reduces
disease susceptibility by a few percent e they consider that the
potential for harm arises when such information is translated into
socially meaningful terms e for instance, when genomic study
results are seen as evidence that a particular group is genetically
inferior to another.
Examples of genomics research that could lead to group harm
When describing possible harm for ethnic groups, interviewees
give important clues about the types of research that could have
such consequences. Genomic research results relating to malaria
were not expected to be particularly sensitive.
“if we do research concerning AIDS and we give the ﬁndings along
the tribal lines, it is like you are watching those tribes. but if you
are doing research on malaria and you mention that these people
are susceptible to malaria there is no shame there” (FW).
Where diseases are already stigmatised research results are
more likely to harm the participating population groups.
“it’s more the association of known stigmatising diseases. For
example if [.] all of the sickle [cell disease variants] were in one
group and not in another group that would be [.] something
which could get sort of publicised and blown up and mishandled
and communities might get feedback that all the bad genes are in
one ethnic group”(R).
In our sample, what interviewees considered important was
whether the disease under investigation was already stigmatised.
Examples of already stigmatised conditions mentioned by the
interviewees were HIV/AIDS and epilepsy. Interviewees mentioned
examples of diseases or conditions that relate to behaviour as being
more likely to lead to harm for the population groups involved,
such as for instance research on alcoholism or intelligence.
“people go looking through the genome for positive selection [.].
So there certainly have been people in the past [.] trying to claim
that there are brain-speciﬁc alleles that have swept up and have
been positively selected that [one ﬁnds] for example only in
Europeans”(R).
The concern is that genomics data could be used to make
normative statements about people of different ethnicities, or
different races. A notorious example mentioned by interviewees is
that of a pioneer geneticist and co-discoverer of the structure of
DNA, who expressed a view that genetic research would lead to thediscovery of genetic factors explaining differences in ‘the power to
reason’ between Africans and Westerners (Milmo, 2007).
Another set of research ﬁndings that may be more sensitive are
ﬁndings that have the potential to be claimed as evidence of what is
considered immoral behaviour. A particular example is data on
extramarital paternity frequencies between ethnic groups, where
these frequencies differ.
“for instance if [.] you write an article and say in this particular
ethnic group we’ve found that 20% of people had a different father
[.] andmost other ethnic groups only have 5% then you start to get
into trouble”(REC).
In some cases, samples were collected from so-called family
trios, comprising a child that was infected with severe malaria, and
its biological parents. In a number of instances, the reported father
was found not to be the genetic father. The frequency with which
this occurs tends to differ between population groups.Where this is
thought to be a proxy for sexual promiscuity, then interviewees
considered this a possible example of harm to the reputation or
integrity of ethnic groups.
A ﬁnal challenge that interviewees identiﬁed arises where
genomics research results are in conﬂict with traditional narratives
of descent. One example is where a population group is composed
of people that were originally enslaved by an ethnic group. These
people now consider themselves fully part of that ethnic group,
whereas their former capturers still consider them as different.
Although the collection of information remains important to
account for population stratiﬁcation, if the results of such studies
were published they could upset the precarious relations between
these ethnic groups.
“I don’t think that to disclose the information in an openway would
be a good idea. We can call them something else. They’re like three
ethnic groups and they’re one, two, three and not [ethnic group A,
ethnic group B]”(R).
Other interviewees also considered that harm could arise where
biological (genetic) accounts of ancestry were in conﬂict with social
narratives.
“But I think that the issue of ancestry and common knowledge or
common beliefs of descent can be sacred, it’s something we really
need to handle with care”(R)
There is some evidence to suggest that a conﬂict between bio-
logical and social or traditional narratives of descent could be
harmful. For instance, in the recent case of the Havasupai in North
America, biological evidence was perceived e by tribal members or
possibly by commentators on the case e to be in conﬂict with the
tribe’s traditional narrative of origin (Harmon, 2010). At least one
author (McGregor, 2010) argued that the group had been harmed as
a result. By contrast, the Lemba e a black Southern African ethnic
group e saw their claims to an ancient Jewish ancestry conﬁrmed
when genetic studies found similarity between the Y chromosome
of some Lemba males, and the Y chromosome carried by contem-
porary members of the Jewish priesthood in Israel (Parﬁtt &
Egorova, 2005). This seems to suggest that genomics research has
a potential to authenticate, challenge or destabilize communal
narratives of origin, and that this may have beneﬁcial or harmful
consequences to the groups involved.
Harm and beneﬁt of repeated inclusion of speciﬁc ethnic groups in
genomics research
Interviewees described both challenges and beneﬁts relating to
the repeated inclusion of some population groups in genomics
research. In some cases, there may be public health value in
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genetically predisposed to certain diseases, or when a group’s
genomic material indicates a difﬁculty in metabolising particular
drugs.
“Say for example there is a particular allele of a gene that is found
in a sub-group and we know that that allele predisposes the pop-
ulation to some level of severity of the disease [.] then you know if
you have this [disease] in this group then you need to watch out
because you know that they harbour a particular gene which will
predispose them to a more severe form of the disease [.] it would
be useful from a medical point of view”(R).
At the same time, interviewees e and especially ethics
committee members e felt that there are also good reasons why
ethnicity should not become part of the rationale for participant
selection.
“you see, we tie it in as a matter of justice. Because you don’t want
to imagine you’re only studying the Kikuyu because they are
Kikuyu or you’re only studying the Luhya because they’re Luhya.
You should be able to study all”(REC).
More importantly, the fear is that particular ethnic groups
would become the target for genomics research. Where there is an
expectation that genomics research could have beneﬁts for the
ethnic group involved e for instance, they become the focus of
further medical research which may improve treatment for that
group both short and long term e repeated exclusion of particular
groups from research may disadvantage those groups. Where only
majority groups are included in research, and minority groups
excluded, the fear is that this could reinforce social inequality
between those groups.
“I can imagine it being a potential problem if there was either a big
focus on a particular group and they might be seen as either getting
favouritism by getting input from the foreign doctors coming and
doing stuff, [.] or it might be this group has been singled out
because they’ve got some dreadful disease, susceptibility and
therefore they’re weaker or there’s some other problem that makes
them different in a bad way”(REC).
There is already some anecdotal evidence that some ethnic
groups in Africa are repeatedly included in medical genomics
research in Africa. For instance, to date the MalariaGEN project
focussed sequencing efforts on ethnic groups from The Gambia
(Jallow et al., 2009), Ghana andMalawi. The same populations from
The Gambia were also included in the ﬁrst GWA study to be
reported in literature, theWellcome Trust Case Control Consortium
(2007). Connections between genomics researchers in MalariaGEN
and other projects has also meant that ethnic groups from The
Gambia, Ghana and Malawi were included in another large geno-
mics research initiative, the 1000 Genomes project (http://www.
1000genomes.org). It will be important to understand what the
ethical implications of the repeated inclusion of certain population
groups in genomics research will be, and whether such inclusion is
likely to generate any harm for those population groups.
Genomics research as a cause of stigma?
Interviewees for this project believed that the risk of genomics
research causing harm to population groups could be elevated
where research is carried out on already stigmatised conditions, on
marginalized population groups, or when research results relate to
what can be considered immoral behaviour. In most other
circumstances, interviewees seemed to consider that the risk of
ethnic stigmatisation is not acute in genomics research, and arises
largely as a side-effect to the original study.“I think that exacerbation [of ethnic stigma] is a more probable
problem than causing [it] because if there isn’t ethnic tension then
the results of scientiﬁc studies are not going to be hitting a fertile
ground in terms of causing tension, I suppose they’d say ‘oh that’s
odd, a proportion of us are different to the others’. [.] The main
risk is where [.] there is already competition between tribes for
power, for position, for land, for inﬂuence. I think when that
happens research results can be used in a way that the researchers
don’t anticipate”(REC).
What this suggests is that genomics research should be
considered not so much as a cause of stigma than as a factor that
could feed into stigma where it is already present. This does not
mean, however, that the use of ethnic categories in genomics
research cannot cause some other form of harm.Means of minimizing the potential for harm
Interviewees argued that a very important component of
understanding the potential harm of using ethnic groups in geno-
mics research relates to understanding the way in which research
results are reported or interpreted.
“if you say one particular group of people is more susceptible to
diabetes [.] I wouldn’t regard that as stigmatisation, I’d regard it
as a fact of life. If on the other hand you said these people have got,
to start getting emotive, they’ve got rotten genes of one sort or
another and they over-eat because they’re lazy and they’re alco-
holics then you start to get into a description of
stigmatisation”(REC).
The issue is that genomics results can be interpreted in ways
that are positive or negative. The onus seems to be on genomics
researchers to commit to presenting research results in ways that
emphasize positive and not negative implications for population
groups.
“It’s two-sided you know because [genomics] can show that people
have different origins, but it can also show that people have
common origins. So [these two tribes] are of the same origin but
they are ﬁghting for many years. You can show them that they have
really no major differences, that they have a recent common origin.
But if you tell [them] that they are different [.] it might have
a blow back”(R).
A related challenge is that genomics research identiﬁes statis-
tical differences between categories of people, but these statistical
differences may not translate into meaningful differences for
medical practice. How to engage with communities in a way that
aptly explains the nature of this difference is a signiﬁcant challenge
for genomics researchers working in Africa.
“We are talking here about statistical differences. With big numbers
even a small difference can be found in statistics. How we can
translate this in ethnic differences that’s the big issue. [.] We
really need to think deeper to see how we can present such
statistical data to a community who don’t know anything about
statistics”(R).
One solution, interviewees suggested, would be to specify in
papers howethnicity wasmeasured, and how research results were
published.
“if you’re going to write about it you have to make sure you’ve
qualiﬁed it you know. You can only talk about ethnicity of that
particular group in that particular area”(R).
This is in line with recommendations made by numerous
authors (see for instance Martin et al., 2007; Shanawani, Dame,
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further investigation, biomedical scientists have resisted calls for
greater care in reporting on race and ethnicity, even when coming
from editors of high-impact scientiﬁc journals (Rose, 2006).
Whether the possibility of harm to ethnic groups will provide more
compelling reasons to qualify the meaning of ethnic group speciﬁc
research results, remains to be seen.
Discussion
Our interviews demonstrate that the relation between genomics
research and stigma is not straightforward, and that claims about
ethnic stigmatisation as one of the outcomes of genomics research
need further substantiation. In line with suggestions made in
literature, our interviewees also tended to describe as problematic
the potential for genomics research to highlight differences in
group susceptibility to disease e in other words, that genomics
research can ‘mark’ particular populations as being more suscep-
tible to disease, and that this would be sufﬁcient to stigmatise those
populations.
But the focus on stigma as a ‘mark’, ‘attribute’ or ‘characteristic’
has been challenged as being reductive and as treating stigma as
something that is ‘mapped onto people, who in turn by virtue of
their difference, are understood to be negatively valued in society”
(Parker & Aggleton, 2003, p. 14). Link and Phelan, amongst others,
have worked to deﬁne stigma as a social process, comprising the
identiﬁcation of targets of stigma, the attribution of normative
beliefs to the targets, and the subsequent labelling of people (Link &
Phelan, 2001). As a social process, stigmatisation builds upon
existing social and power relations and dominant cultural beliefs
about similarity and difference. Simply ascribing difference to
a population group e through genomic research or other means e
would in this understanding of stigma not be sufﬁcient to cause
stigmatisation of that group. Drawing on our ﬁndings, we would
like to suggest that it seems unlikely that genomics research could
be the cause of stigma, but rather that it could be a factor contrib-
uting to the process of stigmatisation. Stigma also entails a process
of embodiment e where possible targets of stigma can internalise
or resist stigma (Parker & Aggleton, 2003; Yang et al., 2007). It
remains unclear how genomic research results that pertain to
population groups, will be internalised and resisted by individual
members of those groups, and how such results will relate to
traditional understandings of disease and inheritance (Fullwiley,
2010). Tekola et al. (2009) found that genomics research ﬁndings
were integrated with traditional understandings of family inheri-
tance and blood relations. Many communities have been found to
have notions of inheritance which could encapsulate novel
genomic knowledge and ﬁndings (Lock & Nguyen, 2010; Simpson,
2000). In the MalariaGEN experience, such notions were some-
times used to explain the genomics research project to research
participants, as we have described elsewhere (De Vries et al., 2011).
Future research should seek to further investigate the relation
between traditional understandings of biological inheritance,
genomics and stigma.
As an alternative, the concept of ‘harm to ethnic groups’ can take
into account other relevant outcomes that are disadvantageous for
ethnic groups but that do not constitute ‘stigma’ in theway that it is
currently understood in literature. Such harm may include for
instance negative publicity for an ethnic group because of partic-
ular genomics research ﬁndings or negative consequences of being
excluded from research based on ethnic afﬁliation.
We have outlined a number of circumstances in which the
likelihood of harm arising as a consequence of genomics research, is
increased. We believe harm is more likely when the ethnic groups
included in research are already stigmatised or discriminated, forinstance in the case of minority groups in a population. We also
believe that we can identify three categories of genomic research
projects or ﬁndings that could signal greater potential for group
harm. These are:
 Disease-related comparisons between ethnic groups when inves-
tigating diseases or conditions with normative implications or
stigmatised conditions. Examples of the ﬁrst are diseases or
conditions that relate to behaviour, for instance sexual
promiscuity, alcoholism or intelligence. Already stigmatised
conditions could be HIV/AIDS, epilepsy, or podoconiosis
(Tekola et al., 2009);
 Findings that are evidence of what is considered to be immoral
behaviour. For instance, data on false paternity frequencies
between ethnic groups. Another example is evidence of
admixture between ethnic groups, where reproduction
between members of two groups is taboo. Evidence of taboo
family relationships such as incest would also fall into this
category;
 Projects looking for evidence of group origin or composition,
where these are in conﬂict with social and traditional narratives.
A recent example is the case of the Havasupai, who argued,
amongst other things, that their inclusion in a genomic study
caused them harm because it provided a genetic narrative of
descent that was in conﬂict with their own beliefs. Where
genomic data conﬁrms traditional narratives, such as was the
case for the Lemba of Southern Africa, such harmful effects do
not seem to arise.
The potential for research projects and results to lead to group
harm corresponds with existing relations between ethnic groups
and with existing stigma. Where relations are not problematic, and
where the disease under question is not stigmatised, there is
limited ground to believe that research results can be used in ways
that constitute harm for participants. But where relations are
strained, or where diseases are stigmatized, there is a much greater
cause for concern.
What our ﬁndings suggest is that there is a clear need for
genomics researchers to take account of the local social context of
the work that they are proposing to do. This may involve careful
preliminary consultations with research participants and their
communities to understand the local realities and relations
between ethnic groups, as well as whether the diseases they are
hoping to investigate are already stigmatised. Our research also
raises a question about whether the potential for group harm
arising out of genomics research should be discussed with
communities and population groups prior to their enrolment in
such research. In addition, many genomics research projects are
funded internationally, and are led by researchers based in
Europe or the United States (Newport & Rotimi, 2009). How the
increasing geographical spacing of research across the globe
inﬂuences researchers’ ability to understand or recognise the
potential for harm needs to be further explored. In addition, there
is also a need to critically examine the implications of repeated
inclusion of speciﬁc ethnic groups in subsequent genomics
research projects.
In this research project, we did not include the perspectives of
research participants in genomics research in Africa for methodo-
logical reasons. The implication is that our work does not address
deeper questions about the relation between genomics research
and stigma as a lived experience for research participants and their
communities (Yang et al., 2007). It is pertinent that future research
examines how the lives of the people participating in genomics
research can be affected by stigma that arises out of or is aggravated
by genomics research.
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